|
DK1783222T3
(da)
|
1998-10-23 |
2012-07-09 |
Kirin Amgen Inc |
Dimere trombopoietiske peptidomimetika, der binder til MPL-receptor og har trombopoietisk aktivitet
|
|
TW200526779A
(en)
|
2001-02-08 |
2005-08-16 |
Wyeth Corp |
Modified and stabilized GDF propeptides and uses thereof
|
|
US7320789B2
(en)
|
2001-09-26 |
2008-01-22 |
Wyeth |
Antibody inhibitors of GDF-8 and uses thereof
|
|
MXPA04008149A
(es)
|
2002-02-21 |
2005-06-17 |
Wyeth Corp |
Proteinas que contienen dominios de folistatina.
|
|
MXPA04008150A
(es)
*
|
2002-02-21 |
2005-06-17 |
Wyeth Corp |
Gasp1: una proteina que contiene dominio de folistatina.
|
|
US7193069B2
(en)
*
|
2002-03-22 |
2007-03-20 |
Research Association For Biotechnology |
Full-length cDNA
|
|
BR0314270A
(pt)
*
|
2002-09-16 |
2005-08-02 |
Univ Johns Hopkins |
Ativação de miostatina com metaloprotease e processos de modulação da atividade da miostatina
|
|
US7261893B2
(en)
|
2002-10-22 |
2007-08-28 |
Wyeth |
Neutralizing antibodies against GDF-8 and uses therefor
|
|
US20040223966A1
(en)
*
|
2002-10-25 |
2004-11-11 |
Wolfman Neil M. |
ActRIIB fusion polypeptides and uses therefor
|
|
EP2272864A3
(en)
*
|
2002-12-20 |
2011-02-16 |
Amgen Inc. |
Binding agents which inhibit myostatin
|
|
US7785587B2
(en)
*
|
2003-06-02 |
2010-08-31 |
Wyeth |
Therapeutic methods for muscular or neuromuscular disorders
|
|
BRPI0406606A
(pt)
|
2003-11-13 |
2005-12-06 |
Hanmi Pharm Ind Co Ltd |
Composição farmacêutica compreendendo uma região fc de imunoglobulina como um veìculo
|
|
US8110665B2
(en)
|
2003-11-13 |
2012-02-07 |
Hanmi Holdings Co., Ltd. |
Pharmaceutical composition comprising an immunoglobulin FC region as a carrier
|
|
WO2005066204A2
(en)
|
2003-12-31 |
2005-07-21 |
Schering-Plough Ltd. |
Neutralizing epitope-based growth enhancing vaccine
|
|
US9045553B2
(en)
|
2004-05-27 |
2015-06-02 |
Acceleron Pharma, Inc. |
Cerberus/Coco derivatives and uses thereof
|
|
WO2005115439A2
(en)
*
|
2004-05-27 |
2005-12-08 |
Acceleron Pharma Inc. |
Cerberus/coco derivatives and uses thereof
|
|
JP2008505928A
(ja)
*
|
2004-07-08 |
2008-02-28 |
アムジェン インコーポレーテッド |
治療用ペプチド
|
|
WO2006036834A2
(en)
*
|
2004-09-24 |
2006-04-06 |
Amgen Inc. |
MODIFIED Fc MOLECULES
|
|
MY144766A
(en)
|
2004-12-30 |
2011-10-31 |
Schering Plough Ltd |
Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
|
|
NZ538097A
(en)
*
|
2005-02-07 |
2006-07-28 |
Ovita Ltd |
Method and compositions for improving wound healing
|
|
BRPI0609449A2
(pt)
*
|
2005-03-23 |
2010-04-06 |
Wyeth Corp |
detecção de agentes de modulação de gdf-8
|
|
JP2008537777A
(ja)
*
|
2005-03-23 |
2008-09-25 |
ワイス |
Ｇｄｆ−８調節剤に対する免疫応答の検出
|
|
EP1909831A4
(en)
|
2005-06-14 |
2013-02-20 |
Amgen Inc |
SELF-BUFFING PROTEIN FORMULATIONS
|
|
US8008453B2
(en)
|
2005-08-12 |
2011-08-30 |
Amgen Inc. |
Modified Fc molecules
|
|
CN101277976B
(zh)
|
2005-10-06 |
2012-04-11 |
伊莱利利公司 |
抗肌抑制素抗体
|
|
UA92504C2
(en)
|
2005-10-12 |
2010-11-10 |
Эли Лилли Энд Компани |
Anti-myostatin monoclonal antibody
|
|
US20090163579A1
(en)
*
|
2005-10-14 |
2009-06-25 |
Daniel Raederstorff |
Novel use of nutraceutical compositions
|
|
US8067562B2
(en)
|
2005-11-01 |
2011-11-29 |
Amgen Inc. |
Isolated nucleic acid molecule comprising the amino acid sequence of SEQ ID NO:1
|
|
US20070149458A1
(en)
*
|
2005-12-06 |
2007-06-28 |
Amgen Inc. |
Uses of myostatin antagonists
|
|
JO3324B1
(ar)
|
2006-04-21 |
2019-03-13 |
Amgen Inc |
مركبات علاجية مجففة بالتبريد تتعلق بالعصارة الهضمية
|
|
UA98308C2
(en)
*
|
2006-09-05 |
2012-05-10 |
Эли Лилли Энд Компани |
Anti-myostatin antibody
|
|
WO2008051383A2
(en)
*
|
2006-10-19 |
2008-05-02 |
Amgen Inc. |
Use of alcohol co-solvents to improve pegylation reaction yields
|
|
WO2008073351A2
(en)
*
|
2006-12-08 |
2008-06-19 |
Acceleron Pharma Inc. |
Uses of cerberus, coco and derivatives thereof
|
|
US8501678B2
(en)
|
2007-03-06 |
2013-08-06 |
Atara Biotherapeutics, Inc. |
Variant activin receptor polypeptides and uses thereof
|
|
TWI573802B
(zh)
|
2007-03-06 |
2017-03-11 |
安美基公司 |
變異之活動素受體多肽及其用途
|
|
EP2162540A2
(en)
|
2007-05-22 |
2010-03-17 |
Amgen Inc. |
Compositions and methods for producing bioactive fusion proteins
|
|
WO2009015345A1
(en)
*
|
2007-07-25 |
2009-01-29 |
Amgen Inc. |
Pharmaceutical compositions comprising fc fusion proteins
|
|
LT2170396T
(lt)
|
2007-08-03 |
2017-03-10 |
Summit (Oxford) Limited |
Vaistų deriniai, skirti diušeno raumenų distrofijos gydymui
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
MX2010002249A
(es)
*
|
2007-08-31 |
2010-03-17 |
Amgen Inc |
Formulacion de proteina de estado solido.
|
|
CA2701032C
(en)
|
2007-09-27 |
2021-01-26 |
Amgen Inc. |
Pharmaceutical formulations
|
|
EP3381445B1
(en)
|
2007-11-15 |
2023-10-25 |
Amgen Inc. |
Aqueous formulation of antibody stablised by antioxidants for parenteral administration
|
|
KR101760758B1
(ko)
|
2008-05-14 |
2017-07-24 |
애그리컬쳐 빅토리아 서비스 피티와이 엘티디 |
질병 및 장애를 치료하기 위한 안지오게닌 또는 안지오게닌 아고니스트의 이용
|
|
ME02652B
(me)
|
2008-11-26 |
2017-06-20 |
Amgen Inc |
Stabilizovana varijanta aktivin iib receptora
|
|
JP5808323B2
(ja)
|
2009-06-22 |
2015-11-10 |
アムジエン・インコーポレーテツド |
化学的に制御されたレドックス状態を用いたタンパク質のリフォールディング
|
|
US8945511B2
(en)
*
|
2009-06-25 |
2015-02-03 |
Paul Weinberger |
Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3
|
|
EP3660032B1
(en)
|
2009-06-25 |
2025-10-22 |
Amgen Inc. |
Capture purification processes for proteins expressed in a non-mammalian system
|
|
AU2010310457B2
(en)
|
2009-10-23 |
2015-07-02 |
Amgen Inc. |
Vial adapter and system
|
|
JO3340B1
(ar)
*
|
2010-05-26 |
2019-03-13 |
Regeneron Pharma |
مضادات حيوية لـعامل تمايز النمو 8 البشري
|
|
KR102513760B1
(ko)
|
2010-06-07 |
2023-03-27 |
암젠 인크 |
약물 전달 장치
|
|
CA2808382A1
(en)
|
2010-08-16 |
2012-02-23 |
Amgen Inc. |
Antibodies that bind myostatin, compositions and methods
|
|
EP2691065B1
(en)
|
2011-03-31 |
2017-03-01 |
Amgen Inc. |
Vial adapter and system
|
|
CA2833748C
(en)
|
2011-04-20 |
2019-07-16 |
Amgen Inc. |
Autoinjector apparatus
|
|
WO2012153337A2
(en)
*
|
2011-05-11 |
2012-11-15 |
Technion Research & Development Foundation Ltd. |
Anti-microbial peptides and uses of same
|
|
EP3335747B1
(en)
|
2011-10-14 |
2021-04-07 |
Amgen Inc. |
Injector and method of assembly
|
|
JP6526414B2
(ja)
|
2011-10-26 |
2019-06-05 |
アムジエン・インコーポレーテツド |
Ｕｖ光曝露から生じるタンパク質の改変と分解を減ずるまたは排除する方法
|
|
FR2982860B1
(fr)
*
|
2011-11-18 |
2015-07-10 |
Ass Fr Contre Les Myopathies |
Utilisation de la fibromoduline et du lumican pour augmenter la masse musculaire
|
|
JP6145112B2
(ja)
|
2011-12-19 |
2017-06-07 |
アムジエン・インコーポレーテツド |
単独でのまたは化学療法と組み合わされた変異アクチビン受容体ポリペプチド、およびその使用
|
|
HK1206764A1
(en)
|
2012-03-26 |
2016-01-15 |
Axcella Health Inc. |
Nutritive proteins and methods
|
|
SG10201604464SA
(en)
|
2012-03-26 |
2016-07-28 |
Axcella Health Inc |
Charged nutritive proteins and methods
|
|
HK1206765A1
(en)
|
2012-03-26 |
2016-01-15 |
Axcella Health Inc. |
Nutritive fragments, proteins and methods
|
|
EP2831102A4
(en)
|
2012-03-26 |
2015-12-02 |
Pronutria Inc |
NUTRITIONAL FRAGMENTS, PROTEINS THEREFOR AND METHOD
|
|
AU2013204740C1
(en)
|
2012-05-10 |
2015-10-01 |
Agriculture Victoria Services Pty Ltd |
Methods of treating cancer using angiogenin or an angiogenin agonist
|
|
ES2791778T3
(es)
|
2012-08-01 |
2020-11-05 |
Ikaika Therapeutics Llc |
Mitigación del daño tisular y la fibrosis a través de anticuerpos anti-LTBP4
|
|
EP3072548B1
(en)
|
2012-11-21 |
2019-03-06 |
Amgen, Inc |
Drug delivery device
|
|
JP6143270B2
(ja)
*
|
2013-01-31 |
2017-06-07 |
学校法人東京薬科大学 |
マイオスタチン阻害ペプチド
|
|
CA2899889A1
(en)
|
2013-02-01 |
2014-08-07 |
Santa Maria Biotherapeutics, Inc. |
Administration of an anti-activin-a compound to a subject
|
|
JP6336564B2
(ja)
|
2013-03-15 |
2018-06-06 |
アムゲン・インコーポレーテッド |
薬物カセット、自動注入器、および自動注入器システム
|
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
|
CN111617347B
(zh)
|
2013-03-15 |
2023-09-29 |
安进公司 |
身体轮廓可调适的自动注射器装置
|
|
EP2976117B1
(en)
|
2013-03-22 |
2020-12-30 |
Amgen Inc. |
Injector and method of assembly
|
|
KR101523065B1
(ko)
*
|
2013-06-19 |
2015-05-27 |
한국기초과학지원연구원 |
입자크기가 제어된 금 나노입자의 제조방법 및 제조된 금 나노입자를 이용한 비색식 강산 검출방법
|
|
TW201601741A
(zh)
*
|
2013-09-09 |
2016-01-16 |
品特生物療法有限公司 |
用於治療ｅｓｒｄ病患之ｐｅｗ的肌肉生長抑制素拮抗劑
|
|
WO2015048334A2
(en)
|
2013-09-25 |
2015-04-02 |
Pronutria, Inc. |
Edible species nutritive polypeptides and methods of production and use thereof
|
|
SG11201602876WA
(en)
|
2013-10-24 |
2016-05-30 |
Amgen Inc |
Injector and method of assembly
|
|
WO2015061389A1
(en)
|
2013-10-24 |
2015-04-30 |
Amgen Inc. |
Drug delivery system with temperature-sensitive control
|
|
US10994112B2
(en)
|
2014-02-05 |
2021-05-04 |
Amgen Inc. |
Drug delivery system with electromagnetic field generator
|
|
SG10201811702TA
(en)
|
2014-05-07 |
2019-01-30 |
Amgen Inc |
Autoinjector with shock reducing elements
|
|
MX387194B
(es)
|
2014-06-03 |
2025-03-18 |
Amgen Inc |
Sistemas y metodos para procesar de manera remota datos recolectados por un dispositivo de suministro de farmaco.
|
|
US9616114B1
(en)
|
2014-09-18 |
2017-04-11 |
David Gordon Bermudes |
Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
|
|
EP3943135B1
(en)
|
2014-10-14 |
2025-09-24 |
Amgen Inc. |
Drug injection device with visual and audible indicators
|
|
JP6706617B2
(ja)
|
2014-11-06 |
2020-06-10 |
スカラー ロック インコーポレイテッドＳｃｈｏｌａｒ Ｒｏｃｋ，Ｉｎｃ． |
抗プロ／潜在型−ミオスタチン抗体およびその使用
|
|
US10799630B2
(en)
|
2014-12-19 |
2020-10-13 |
Amgen Inc. |
Drug delivery device with proximity sensor
|
|
EP3689394A1
(en)
|
2014-12-19 |
2020-08-05 |
Amgen Inc. |
Drug delivery device with live button or user interface field
|
|
ES2748750T3
(es)
|
2015-02-17 |
2020-03-17 |
Amgen Inc |
Dispositivo de administración de fármacos con sujeción asistida por vacío y/o realimentación
|
|
US11806509B2
(en)
|
2015-02-27 |
2023-11-07 |
Amgen Inc. |
Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement
|
|
BR112017022621A2
(pt)
*
|
2015-04-23 |
2018-07-17 |
Baker Idi Heart And Diabetes Inst |
liberação do gene de smad7 como uma substância terapêutica
|
|
CN106191215B
(zh)
*
|
2015-04-29 |
2020-03-24 |
中国科学院上海生命科学研究院 |
肌肉萎缩相关的蛋白质分子标记Dkk-3的筛选及其应用
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
EP3334747B1
(en)
|
2015-08-13 |
2023-09-27 |
Amgen Inc. |
Charged depth filtration of antigen-binding proteins
|
|
WO2017039786A1
(en)
|
2015-09-02 |
2017-03-09 |
Amgen Inc. |
Syringe assembly adapter for a syringe
|
|
US11351308B2
(en)
|
2015-12-09 |
2022-06-07 |
Amgen Inc. |
Auto-injector with signaling cap
|
|
US11154661B2
(en)
|
2016-01-06 |
2021-10-26 |
Amgen Inc. |
Auto-injector with signaling electronics
|
|
US10287345B2
(en)
|
2016-01-08 |
2019-05-14 |
Scholar Rock, Inc. |
Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies
|
|
EP3429663B1
(en)
|
2016-03-15 |
2020-07-15 |
Amgen Inc. |
Reducing probability of glass breakage in drug delivery devices
|
|
RU2613420C1
(ru)
*
|
2016-04-13 |
2017-03-16 |
Сергей Михайлович Юдин |
Рекомбинантный белок Мио-ГСД, способ его получения, инъекционный препарат для повышения мышечной массы сельскохозяйственных животных, птицы и животных семейства псовых, а также способ использования препарата
|
|
EP3448414B1
(en)
*
|
2016-04-25 |
2024-04-17 |
Five Prime Therapeutics, Inc. |
Nope for treatment of pathological muscle loss and weakness
|
|
US11541168B2
(en)
|
2016-04-29 |
2023-01-03 |
Amgen Inc. |
Drug delivery device with messaging label
|
|
US11389588B2
(en)
|
2016-05-02 |
2022-07-19 |
Amgen Inc. |
Syringe adapter and guide for filling an on-body injector
|
|
JP7309363B2
(ja)
|
2016-05-13 |
2023-07-18 |
アムジエン・インコーポレーテツド |
バイアル・スリーブ組立体
|
|
US11238150B2
(en)
|
2016-05-16 |
2022-02-01 |
Amgen Inc. |
Data encryption in medical devices with limited computational capability
|
|
WO2017209899A1
(en)
|
2016-06-03 |
2017-12-07 |
Amgen Inc. |
Impact testing apparatuses and methods for drug delivery devices
|
|
EP3478342B1
(en)
|
2016-07-01 |
2025-03-12 |
Amgen Inc. |
Drug delivery device having minimized risk of component fracture upon impact events
|
|
US10150115B2
(en)
*
|
2016-07-21 |
2018-12-11 |
Spacepharma SA |
System and method for rehydrating powder and delivering the rehydrated powder to a reactor
|
|
WO2018034784A1
(en)
|
2016-08-17 |
2018-02-22 |
Amgen Inc. |
Drug delivery device with placement detection
|
|
AU2017345490B2
(en)
|
2016-10-21 |
2022-07-07 |
Amgen Inc. |
Pharmaceutical formulations and methods of making the same
|
|
US20200261643A1
(en)
|
2016-10-25 |
2020-08-20 |
Amgen Inc. |
On-body injector
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
US11129906B1
(en)
|
2016-12-07 |
2021-09-28 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
SI3565592T1
(sl)
*
|
2017-01-06 |
2023-05-31 |
Scholar Rock, Inc. |
Zdravljenje presnovnih bolezni z zaviranjem aktivacije miostatina
|
|
MX2019008432A
(es)
|
2017-01-17 |
2019-11-18 |
Amgen Inc |
Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
|
|
MX2019009755A
(es)
|
2017-02-17 |
2019-10-07 |
Amgen Inc |
Mecanismo de insercion para dispositivo de suministro de farmacos.
|
|
US11752258B2
(en)
|
2017-02-17 |
2023-09-12 |
Amgen Inc. |
Drug delivery device with sterile fluid flowpath and related method of assembly
|
|
WO2018165143A1
(en)
|
2017-03-06 |
2018-09-13 |
Amgen Inc. |
Drug delivery device with activation prevention feature
|
|
WO2018164829A1
(en)
|
2017-03-07 |
2018-09-13 |
Amgen Inc. |
Needle insertion by overpressure
|
|
IL268386B2
(en)
|
2017-03-09 |
2023-11-01 |
Amgen Inc |
Insertion mechanism for a drug delivery device
|
|
PL3600491T3
(pl)
|
2017-03-28 |
2024-03-04 |
Amgen Inc. |
Układ i sposób montażu trzonu tłoka i strzykawki
|
|
EP3634546A1
(en)
|
2017-06-08 |
2020-04-15 |
Amgen Inc. |
Torque driven drug delivery device
|
|
WO2018226515A1
(en)
|
2017-06-08 |
2018-12-13 |
Amgen Inc. |
Syringe assembly for a drug delivery device and method of assembly
|
|
WO2018236619A1
(en)
|
2017-06-22 |
2018-12-27 |
Amgen Inc. |
Device activation impact/shock reduction
|
|
JP7475860B2
(ja)
|
2017-06-23 |
2024-04-30 |
アムジエン・インコーポレーテツド |
スイッチアセンブリにより起動されるキャップを含む電子薬物送達デバイス
|
|
EP3651832B1
(en)
|
2017-07-14 |
2023-12-13 |
Amgen Inc. |
Needle insertion-retraction system having dual torsion spring system
|
|
US11672733B2
(en)
|
2017-07-21 |
2023-06-13 |
Amgen Inc. |
Gas permeable sealing member for drug container and methods of assembly
|
|
JP2020528296A
(ja)
|
2017-07-25 |
2020-09-24 |
アムジエン・インコーポレーテツド |
ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
|
|
JP7242562B2
(ja)
|
2017-07-25 |
2023-03-20 |
アムジエン・インコーポレーテツド |
容器アクセスシステムを有する薬物送達デバイス及び関連する組立方法
|
|
US12318593B2
(en)
|
2017-08-09 |
2025-06-03 |
Amgen Inc. |
Hydraulic-pneumatic pressurized chamber drug delivery system
|
|
EP3668567A1
(en)
|
2017-08-18 |
2020-06-24 |
Amgen Inc. |
Wearable injector with sterile adhesive patch
|
|
US11103636B2
(en)
|
2017-08-22 |
2021-08-31 |
Amgen Inc. |
Needle insertion mechanism for drug delivery device
|
|
US11759565B2
(en)
|
2017-10-04 |
2023-09-19 |
Amgen Inc. |
Flow adapter for drug delivery device
|
|
EP3691716B1
(en)
|
2017-10-06 |
2023-11-29 |
Amgen Inc. |
Drug delivery device with interlock assembly and related method of assembly
|
|
IL273323B2
(en)
|
2017-10-09 |
2024-10-01 |
Amgen Inc |
Drug delivery device with drive assembly and related assembly method
|
|
US11826480B2
(en)
|
2017-11-03 |
2023-11-28 |
Amgen Inc. |
Systems and approaches for sterilizing a drug delivery device
|
|
MA50553A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Dispositif d'administration de médicament avec détection de positionnement et de débit
|
|
MA50569A
(fr)
|
2017-11-06 |
2020-09-16 |
Amgen Inc |
Ensembles de remplissage-finition et procédés associés
|
|
SG11202002966QA
(en)
|
2017-11-10 |
2020-05-28 |
Amgen Inc |
Plungers for drug delivery devices
|
|
JP7747438B2
(ja)
|
2017-11-16 |
2025-10-01 |
アムジエン・インコーポレーテツド |
失速及び終点検出を有するオートインジェクタ
|
|
AU2018368340B2
(en)
|
2017-11-16 |
2024-03-07 |
Amgen Inc. |
Door latch mechanism for drug delivery device
|
|
EP3569614A1
(en)
|
2018-05-18 |
2019-11-20 |
Julius-Maximilians-Universität Würzburg |
Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase
|
|
US10835685B2
(en)
|
2018-05-30 |
2020-11-17 |
Amgen Inc. |
Thermal spring release mechanism for a drug delivery device
|
|
US11083840B2
(en)
|
2018-06-01 |
2021-08-10 |
Amgen Inc. |
Modular fluid path assemblies for drug delivery devices
|
|
KR102259645B1
(ko)
|
2018-07-16 |
2021-06-02 |
강릉원주대학교산학협력단 |
구멍쇠미역 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
KR102042352B1
(ko)
|
2018-07-16 |
2019-11-07 |
강릉원주대학교산학협력단 |
땅콩 껍질 추출물을 포함하는 근력강화 또는 근감소증의 예방 및 치료용 조성물
|
|
WO2020023220A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with tacky skin attachment portion and related method of preparation
|
|
WO2020023336A1
(en)
|
2018-07-24 |
2020-01-30 |
Amgen Inc. |
Hybrid drug delivery devices with grip portion
|
|
EP3826701A1
(en)
|
2018-07-24 |
2021-06-02 |
Amgen Inc. |
Delivery devices for administering drugs
|
|
MX2021000749A
(es)
|
2018-07-24 |
2021-03-29 |
Amgen Inc |
Dispositivos de suministro para administrar farmacos.
|
|
WO2020028009A1
(en)
|
2018-07-31 |
2020-02-06 |
Amgen Inc. |
Fluid path assembly for a drug delivery device
|
|
JP2022500095A
(ja)
|
2018-09-24 |
2022-01-04 |
アムジエン・インコーポレーテツド |
インターベンション投薬システム及び方法
|
|
IL281469B2
(en)
|
2018-09-28 |
2024-08-01 |
Amgen Inc |
Muscle wire escapement activation assembly for a drug delivery device
|
|
EP3860685A1
(en)
|
2018-10-02 |
2021-08-11 |
Amgen Inc. |
Injection systems for drug delivery with internal force transmission
|
|
US12151089B2
(en)
|
2018-10-05 |
2024-11-26 |
Amgen Inc. |
Drug delivery device having dose indicator
|
|
MA53912A
(fr)
|
2018-10-15 |
2022-01-19 |
Amgen Inc |
Dispositif d'administration de médicament comprenant un mécanisme d'amortissement
|
|
SG11202101824VA
(en)
|
2018-10-15 |
2021-03-30 |
Amgen Inc |
Platform assembly process for drug delivery device
|
|
CA3115296A1
(en)
|
2018-10-23 |
2020-04-30 |
Amgen Inc. |
Automatic calibration and automatic maintenance of raman spectroscopic models for real-time predictions
|
|
AU2019370159B2
(en)
|
2018-11-01 |
2025-05-29 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
EP3873566B1
(en)
|
2018-11-01 |
2024-11-27 |
Amgen Inc. |
Drug delivery devices with partial drug delivery member retraction
|
|
TWI831847B
(zh)
|
2018-11-01 |
2024-02-11 |
美商安進公司 |
部分針頭縮回之藥物遞送裝置及其操作方法
|
|
KR20210117271A
(ko)
|
2018-12-21 |
2021-09-28 |
노쓰웨스턴유니버시티 |
근막 손상 예방 및 치료를 위한 아넥신의 사용근각 손상 예방 및 치료를 위한 아넥신의 사용
|
|
WO2020139977A1
(en)
|
2018-12-26 |
2020-07-02 |
Northwestern University |
Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder
|
|
US20220160972A1
(en)
|
2019-04-24 |
2022-05-26 |
Amgen Inc. |
Syringe sterilization verification assemblies and methods
|
|
JP7608439B2
(ja)
|
2019-08-23 |
2025-01-06 |
アムジエン・インコーポレーテツド |
構成可能な針シールド係合構成要素を備えた薬物送達デバイス及び関連方法
|
|
US20230071627A1
(en)
|
2020-02-03 |
2023-03-09 |
Amgen Inc. |
Multivariate Bracketing Approach for Sterile Filter Validation
|
|
US20240208680A1
(en)
|
2021-05-21 |
2024-06-27 |
Amgen Inc. |
Method of optimizing a filling recipe for a drug container
|
|
WO2023076318A1
(en)
|
2021-10-27 |
2023-05-04 |
Amgen Inc. |
Deep learning-based prediction for monitoring of pharmaceuticals using spectroscopy
|
|
KR102726402B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
WO2023096232A1
(ko)
*
|
2021-11-25 |
2023-06-01 |
(주)네오크레마 |
신규 펩티드 및 이의 용도
|
|
US20250082720A1
(en)
*
|
2021-11-25 |
2025-03-13 |
Neo Cremar Co., Ltd. |
New peptide and uses thereof
|
|
KR102726401B1
(ko)
*
|
2021-11-25 |
2024-11-05 |
(주)네오크레마 |
지방전구세포의 증식과 지방세포로의 분화를 억제하는 신규 펩티드 및 이의 용도
|
|
CN115403657A
(zh)
*
|
2022-06-23 |
2022-11-29 |
浙江大学 |
一种TGF-β3生长因子的亲和多肽及其应用
|
|
KR20250122524A
(ko)
|
2022-12-22 |
2025-08-13 |
스칼러 락, 인크. |
미오스타틴 활성화의 선택적이고 강력한 억제 항체
|
|
WO2025037108A2
(en)
|
2023-08-15 |
2025-02-20 |
Board Of Trustees Of The Leland Stanford Junior University |
Modified thrombopoietin
|